Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
symptoms of fever, muscle aches, injection site pain and headaches; symptoms of fever, muscle aches, injection site pain and headaches; symptoms of fever, muscle aches, injection site pain and headaches; symptoms of fever, muscle aches, injection site pain and headaches; This spontaneous report was received from a pharmacist and refers to a 60-year-old female patient. The patient's medical history included Neuropathy, and Leukemia. The patient's concurrent condition included compromised immune system. Concomitant medication included Gabapentin . On 06-FEB-2025 (reported as last Thursday), the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) 0.5 mL once, (strength, lot # and expiration date were not reported) for pneumonia prevention. On 07-FEB-2025 (also reported as the day after), the patient started having symptoms of fever, muscle aches, injection site pain and headaches. The patient hadn't seen their doctor to discuss their symptoms, but they were still dealing with the headaches and fever currently. They said that it wasn't something that was life threatening, but they were concerned because of their health history. At the reporting time, the patient had not recovered from the events. The action taken was not applicable. The causal relationship between the events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not reported.
Immunocompromised
Medical History/Concurrent Conditions: Leukemia; Neuropathy
GABAPENTIN